Generation Bio Inc. (GBIO): Price and Financial Metrics
GBIO Price/Volume Stats
| Current price | $0.96 | 52-week high | $4.65 |
| Prev. close | $0.99 | 52-week low | $0.75 |
| Day low | $0.94 | Volume | 383,500 |
| Day high | $1.02 | Avg. volume | 783,300 |
| 50-day MA | $1.29 | Dividend yield | N/A |
| 200-day MA | $2.42 | Market Cap | 63.83M |
GBIO Stock Price Chart Interactive Chart >
Generation Bio Inc. (GBIO) Company Bio
Generation Bio Co. is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.
GBIO Price Returns
| 1-mo | -12.73% |
| 3-mo | -55.76% |
| 6-mo | -72.65% |
| 1-year | -48.39% |
| 3-year | -85.21% |
| 5-year | N/A |
| YTD | -9.43% |
| 2024 | -35.76% |
| 2023 | -58.02% |
| 2022 | -44.49% |
| 2021 | -75.03% |
| 2020 | N/A |
Loading social stream, please wait...